Personalis Personalis Reports Preliminary Q4 Revenues up More Than 2 Percent The company is expecting continued growth in its oncology orders in Q4 2021 to translate to significant revenue growth for that business next year. Fulgent Genetics, Bio-Techne Lead Winners as GenomeWeb Index Gains 12 Percent in 2021 While Fulgent's stock price nearly doubled, at the other end of the spectrum, Berkeley Lights saw an 80 percent decline in its share price. Personalis Signs Deal With BTIG for $100M At-Market Stock Offering The company said any proceeds raised will support working capital and general corporate purposes, including research and development programs. New Products Posted to GenomeWeb: Thermo Fisher, Personalis, Menarini Silicon Biosystems, More Personalis Q3 Revenues Climb 12 Percent The company saw less revenue from the VA MVP during the quarter but reported a surge in both revenue and new orders from non-VA pharma and other customers. Oct 15, 2021 People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More Oct 13, 2021 Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration Aug 4, 2021 Personalis Q2 Revenues Rise 11 Percent Aug 2, 2021 GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases May 5, 2021 Personalis Q1 Revenues Grow 9 Percent Mar 30, 2021 MapKure, Personalis Partner to Screen Patients for BRAF Inhibitor Trial Mar 2, 2021 Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent Feb 26, 2021 Personalis to Broaden Liquid Biopsy Footprint With Minimal Residual Disease Testing Premium Feb 25, 2021 Personalis Q4 Revenues up 11 Percent Feb 17, 2021 Natera, Personalis Team up for Cancer Treatment Monitoring, MRD Testing Jan 27, 2021 Personalis Prices $150M Public Stock Offering Jan 12, 2021 Personalis Projects 2020 Q4 Revenues Up 11 Percent Dec 23, 2020 Personalis Sees New Neoantigen Platform Driving Improved Immunotherapy Prediction Premium Dec 18, 2020 New Products Posted to GenomeWeb: Personalis, AutoGen, Celemics, More Nov 5, 2020 Personalis Q3 Revenues Up 16 Percent Aug 12, 2020 Personalis Prices $125M Public Stock Offering Aug 7, 2020 New Products Posted to GenomeWeb: Illumina, Adaptive Biotechnologies, Personalis, More Aug 6, 2020 Personalis Q2 Revenues Up 23 Percent Jul 17, 2020 People in the News: New Appointments at Personalis, Predictive Oncology, HalioDx Jun 10, 2020 Personalis Taps Berry Genomics to Facilitate Expansion in China Load More Breaking News Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering Dante Labs to Refund COVID-19 Test Customers Following UK Regulatory Investigation Lifespan Linked to Lower Protein Synthesis Gene Expression Pathogenic Variants in Disease-Causing Genes Have Low Penetrance on Average, Study Finds The Scan Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian. Fulgent Seeking Defamation Suit Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports. Speeding Gene-Edited Crops Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there. Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.